Stock listing

Nanobiotix Sa

Selected listing: 0QAV · LSE · EUR · GB

Nanobiotix Sa (LSE:0QAV), Health Technology. Latest release Oct 1, 2026: NANOBIOTIX Announces the Appointment of Arnd Christ as Chief Financial Officer.

0QAV:LSEEURGBUpdated October 3, 2026

Ticker: LSE:0QAV
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: LSE
Currency: EUR

About Nanobiotix Sa

The company focuses on innovative cancer treatments using nanotechnology. Their approach aims to enhance the effectiveness of radiotherapy and improve patient outcomes.

Latest news from Nanobiotix Sa

NANOBIOTIX Announces the Appointment of Arnd Christ as Chief Financial Officer

October 1, 2026

NANOBIOTIX annonce la nomination d’Arnd Christ au poste de directeur financier

September 30, 2026

NANOBIOTIX Provides First Half 2026 Operational and Financial Update

September 24, 2026

NANOBIOTIX fait le point sur ses activités et ses résultats financiers du premier semestre 2026

September 23, 2026

NANOBIOTIX Announces Complete Full Cohort Phase 1 Results for JNJ-1900 (NBTXR3) in Inoperable, Recurrent Non-Small Cell Lung Cancer

September 14, 2026

All Nanobiotix Sa news →

Events

Replays

Nanobiotix S.A. (NBTX) Q4 2025 Earnings Call
Wed, Apr 01, 2026 · 08:00 AM ET
Watch
Nanobiotix S.A. (NBTX) Q4 2024 Earnings Call
Thu, Apr 03, 2025 · 08:00 AM ET
Watch
Nanobiotix S.A. (NBTX) Q1 2024 Earnings Call
Wed, May 22, 2024 · 08:00 AM ET
Watch

Research Nanobiotix Sa

Nanobiotix Sa company profile

View the public company page for Nanobiotix Sa on 6ix.

Nanobiotix Sa news

Read company news and market updates connected to Nanobiotix Sa.

Nanobiotix Sa investor events

Find investor webinars, events, and replay context for Nanobiotix Sa.